MedPath

Efficacy of Physiotherapy on the Health and Quality of Life of the Rheumatic Patient

Phase 2
Conditions
Rheumatic Arthritis
Interventions
Other: Physiotherapy
Other: Wait list control
Registration Number
NCT02020668
Lead Sponsor
Macmillan Research Group UK
Brief Summary

Despite leading cause of morbidity, treatment strategies for Rheumatic diseases are geared almost exclusively toward medical-pharmacological area away from offering the patient the possibility of an interdisciplinary approach to their disease.

Present study test whether treatment of physiotherapy reduces stiffness and pain inherent in rheumatic disease and improve their quality of life related to health.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
82
Inclusion Criteria
  • Patients older than 18 years
  • History of Rheumatoid Arthritis (RA) symptoms for less than 7 years
  • Had RA by American College of Rheumatology (ACR) criteria
  • ACR functional RA class I, II or III
  • Hemoglobin more than 8g/dL without evidence of active bleeding
  • Positive for rheumatoid factor (RF) or anti cyclic citrullinated protein
  • standard conventional medicine were allowed within the approved dosage regimen
Exclusion Criteria
  • connective tissue disease
  • any other alternative or complementary medicine with in last 3 months.
  • corticosteroid, disease modifying medicines
  • Poorly controlled diabetes, hypertension, hepatitis, cardiac disease, liver diseases, carcinoma, drug abuse

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PhysiotherapyPhysiotherapyPhysiotherapy included joint protection strategies, performance of therapeutic exercises and patient education.
Wait list controlWait list controlWait list control received standard care and were invited to join the physiotherapy once intervention period is finished.
Primary Outcome Measures
NameTimeMethod
PainChange from baseline in Numerical Scale Downie at 16 weeks
Secondary Outcome Measures
NameTimeMethod
Quality of LifeChange from Baseline in Short Form (SF) 36 at 16 weeks

Trial Locations

Locations (1)

Life Line Hospital

🇮🇳

Sikar, Rajasthan, India

© Copyright 2025. All Rights Reserved by MedPath